Mínimo 3 entidades de 3 países
Cell-Free Protein Synthesis (CFPS) has been employed in fundamental biological research for decades, however, interest for the approach as a viable means for drug development and production has only emerged in recent years. The advantages that CFPS provides in terms of efficiency, simplicity, flexibility, cost- and time savings outweigh the hurdles that are still to be overcome for CFPS to become a routine manufacturing system for peptide- or protein-based biologicals.
Ver en el portal de la ComisiónFuente:Portal Funding & Tenders (Comisión Europea), actualizado el 29 oct 2026